Academic Medical Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Academic Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9394
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Academic Medical Center (AMC), a subsidiary of University of Amsterdam is a medical center that offers research and educational services. The center offers services such as medical research, treatment of patients, and medical education services, among others. It provides its medical treatments and services for category of diseases, among others. AMC offers research programs in areas of epidemiology, gastrointestinal diseases, cardiovascular diseases, metabolic disorders, Infection and immunity, neurological and psychiatric disorders, reproduction and development, and oncology, among others. The center offers research through its medical and research departments, academic psychiatric centers and tropical institute. AMC is headquartered in Amsterdam, the Netherlands.

Academic Medical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Academic Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Academic Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Academic Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Academic Medical Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Caelus Health Enters into Option Agreement with Academic Medical Center 11
Viking Therapeutics Enters into Research Agreement with Academic Medical Center 12
Equity Offering 13
Caelus Health Spin Off from Wageningen University and Academic Medical Center 13
Academic Medical Center – Key Competitors 14
Academic Medical Center – Key Employees 15
Academic Medical Center – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Academic Medical Center, Pharmaceuticals & Healthcare, Key Facts 2
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Academic Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Academic Medical Center, Deals By Therapy Area, 2012 to YTD 2018 8
Academic Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Academic Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Caelus Health Enters into Option Agreement with Academic Medical Center 11
Viking Therapeutics Enters into Research Agreement with Academic Medical Center 12
Caelus Health Spin Off from Wageningen University and Academic Medical Center 13
Academic Medical Center, Key Competitors 14
Academic Medical Center, Key Employees 15
Academic Medical Center, Joint Venture 16

List of Figures
Academic Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Academic Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Academic Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Academic Medical Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Academic Medical Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Grupo Televisa, S.A.B. (TLEVISACPO):企業の財務・戦略的SWOT分析
    Grupo Televisa, S.A.B. (TLEVISACPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Dr. August Oetker Kg:企業の戦略・SWOT・財務分析
    Dr. August Oetker Kg - Strategy, SWOT and Corporate Finance Report Summary Dr. August Oetker Kg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Network Rail Limited:企業の戦略・SWOT・財務分析
    Network Rail Limited - Strategy, SWOT and Corporate Finance Report Summary Network Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SIG Combibloc Group Ltd.:企業の戦略・SWOT・財務情報
    SIG Combibloc Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary SIG Combibloc Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Seegene Inc (096530):医療機器:M&Aディール及び事業提携情報
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • Bank Hapoalim Private Banking:企業の戦略・SWOT・財務情報
    Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Midatech Pharma Plc (MTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Northern Sun Mining Corp:企業の戦略・SWOT・財務分析
    Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ARCA biopharma Inc (ABIO):企業の財務・戦略的SWOT分析
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • FirstGroup plc (FGP):企業の財務・戦略的SWOT分析
    FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BrainLAB AG:企業の戦略的SWOT分析
    BrainLAB AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • EVRY ASA:企業の戦略・SWOT・財務情報
    EVRY ASA - Strategy, SWOT and Corporate Finance Report Summary EVRY ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報
    Summary LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antib …
  • PharmaLundensis AB:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • Neiman Marcus Group LTD LLC:戦略・SWOT・企業財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Department of Defense Education Activity:企業の戦略的SWOT分析
    Department of Defense Education Activity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • IHI Corp (7013):電力:M&Aディール及び事業提携情報
    Summary IHI Corp (IHI) is a heavy machinery manufacturer. It provides technology oriented products and services to customers in the public, private and industrial sectors across the world. The group designs and manufactures a diverse range of products that includes ships and offshore facilities, str …
  • Aspen Technology, Inc. (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology, Inc. (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆